DE:INFLARX
InflaRx
- Stock
locale
Germanymarket
STOCKSindustry
Biotechnologywebsite
www.inflarx.delinkedin
inflarxipo date
Nov 07, 2017
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a novel intravenously delivered first-...Show More